Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
PDEX Stock Forecast 2026-2027
$63.72
Current Price
$203.44M
Market Cap
Buy 1
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to PDEX Price Targets
+9.9%
To High Target of $70.00
+9.9%
To Median Target of $70.00
+9.9%
To Low Target of $70.00
PDEX Price Momentum
-2.0%
1 Week Change
+7.5%
1 Month Change
+57.1%
1 Year Change
+65.6%
Year-to-Date Change
-7.6%
From 52W High of $68.99
+171.5%
From 52W Low of $23.47
📊 TOP ANALYST CALLS
Did PDEX Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Pro-Dex is one of their latest high-conviction picks.
Latest PDEX Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, PDEX has a bullish consensus with a median price target of $70.00 (ranging from $70.00 to $70.00). The overall analyst rating is Strong Buy (10.0/10). Currently trading at $63.72, the median forecast implies a 9.9% upside. This outlook is supported by 1 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Edward Woo at Ascendiant Capital, projecting a 9.9% upside. Conversely, the most conservative target is provided by Edward Woo at Ascendiant Capital, suggesting a 9.9% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
PDEX Analyst Ratings
1
Buy
0
Hold
0
Sell
PDEX Price Target Range
Low
$70.00
Average
$70.00
High
$70.00
Current: $63.72
Latest PDEX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for PDEX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 12, 2026 | Ascendiant Capital | Edward Woo | Buy | Maintains | $70.00 |
| May 27, 2025 | Ascendiant Capital | Buy | Maintains | $N/A | |
| Feb 22, 2025 | Ascendiant Capital | Buy | Maintains | $N/A | |
| Nov 11, 2024 | Ascendiant Capital | Buy | Maintains | $N/A | |
| Sep 9, 2024 | Ascendiant Capital | Buy | Maintains | $N/A | |
| Jan 4, 2017 | Ascendiant Capital | Buy | Initiates | $N/A |
Pro-Dex Inc. (PDEX) Competitors
The following stocks are similar to Pro-Dex based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Pro-Dex Inc. (PDEX) Financial Data
Pro-Dex Inc. has a market capitalization of $203.44M with a P/E ratio of 17.6x. The company generates $74.64M in trailing twelve-month revenue with a 16.1% profit margin.
Revenue growth is +14.6% quarter-over-quarter, while maintaining an operating margin of +15.5% and return on equity of +29.8%.
Valuation Metrics
Market Cap
$203.44M
Enterprise Value
$212.64M
P/E Ratio
17.6x
PEG Ratio
0.7x
Price/Sales
2.7x
Growth & Margins
Revenue Growth (YoY)
+14.6%
Gross Margin
+30.7%
Operating Margin
+15.5%
Net Margin
+16.1%
EPS Growth
+20.2%
Financial Health
Cash/Price Ratio
+5.4%
Current Ratio
3.7x
Debt/Equity
44.6x
ROE
+29.8%
ROA
+9.7%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Pro-Dex Inc. (PDEX) Business Model
About Pro-Dex Inc.
What They Do
Manufacturer of precision machined products.
Business Model
The company designs and produces high-precision electric and pneumatic motors for the medical and dental industries, generating revenue through customized solutions and manufacturing services for clients, including top-tier medical device companies.
Additional Information
Headquartered in Irvine, California, Pro-Dex emphasizes quality and innovation in its offerings and also serves sectors beyond healthcare, such as industrial automation, showcasing its versatility in precision engineering.
Company Information
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
179
CEO
Mr. Richard Lee Van Kirk Jr.
Country
United States
IPO Year
1995
Website
www.pro-dex.comPro-Dex Inc. (PDEX) Latest News & Analysis
Latest News
Pro-Dex: Still A Buy, But Don't Chase
1 month ago
Quick Summary
Pro-Dex Q1 sales reached $19.9M, up 14.6% YoY. A major customer contract extends to December 2028, lowering near-term risks. APM acquisition enhances supply chain control and offers aerospace/defense opportunities.
Why It Matters
Pro-Dex's Q1 sales growth and extended customer contract mitigate risks, while the APM acquisition enhances supply chain control and opens aerospace/defense opportunities, boosting future prospects.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
PRO-DEX, INC. (NasdaqCM:PDEX) reported its financial results for Q3 of fiscal 2026, ending March 31, 2026. Detailed results were not provided in the excerpt.
Why It Matters
The financial results for PRO-DEX, INC. could impact stock performance, influence investor sentiment, and provide insights into the company's growth and profitability trends.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
PRO-DEX, INC. (NasdaqCM:PDEX) completed the acquisition of Advanced Precision Machining LLC on February 9, 2026. APM is a manufacturing facility based in Costa Mesa, California.
Why It Matters
The acquisition of Advanced Precision Machining enhances PRO-DEX's manufacturing capabilities, potentially boosting revenue and market position, which could positively impact stock performance.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Pro-Dex, Inc. (NasdaqCM:PDEX) has released its financial results for Q2 of fiscal 2026, ending December 31, 2025. Further details on the results were not provided in the excerpt.
Why It Matters
Pro-Dex's financial results can signal its performance trends and future growth potential, impacting stock valuation and investor sentiment.
Source: Accesswire
Market Sentiment:
Neutral
Quick Summary
Pro-Dex (PDEX) manufactures powered surgical instruments for various medical procedures but relies heavily on one customer, which accounts for 78% of its revenue.
Why It Matters
Pro-Dex's revenue reliance on one customer poses significant risk. If that relationship falters, financial performance could drastically decline, impacting stock stability and investor confidence.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Pro-Dex Inc. shows strong growth and efficient capital use but faces customer concentration risk. It trades at ~16x recurrent earnings, appealing for small positions amid favorable healthcare trends.
Why It Matters
Pro-Dex Inc.'s strong growth, efficient capital use, and fair valuation at 16x earnings suggest potential upside, while customer concentration risk requires caution despite supportive healthcare trends.
Source: Seeking Alpha
Market Sentiment:
Positive
Frequently Asked Questions About PDEX Stock
What is Pro-Dex Inc.'s (PDEX) stock forecast for 2026?
Based on our analysis of 2 Wall Street analysts, Pro-Dex Inc. (PDEX) has a median price target of $70.00. The highest price target is $70.00 and the lowest is $70.00.
Is PDEX stock a good investment in 2026?
According to current analyst ratings, PDEX has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $63.72. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for PDEX stock?
Wall Street analysts predict PDEX stock could reach $70.00 in the next 12 months. This represents a 9.9% increase from the current price of $63.72. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Pro-Dex Inc.'s business model?
The company designs and produces high-precision electric and pneumatic motors for the medical and dental industries, generating revenue through customized solutions and manufacturing services for clients, including top-tier medical device companies.
What is the highest forecasted price for PDEX Pro-Dex Inc.?
The highest price target for PDEX is $70.00 from Edward Woo at Ascendiant Capital, which represents a 9.9% increase from the current price of $63.72.
What is the lowest forecasted price for PDEX Pro-Dex Inc.?
The lowest price target for PDEX is $70.00 from Edward Woo at Ascendiant Capital, which represents a 9.9% increase from the current price of $63.72.
What is the overall PDEX consensus from analysts for Pro-Dex Inc.?
The overall analyst consensus for PDEX is bullish. Out of 2 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $70.00.
How accurate are PDEX stock price projections?
Stock price projections, including those for Pro-Dex Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 16, 2026 12:12 PM UTC